Hot Topics in SpA

Patient Selection

Healio spoke with Delamo I. Bekele, MBBS, clinical rheumatologist and assistant professor of medicine at Mayo Clinic, and Devon Charlton, MD, rheumatologist at University of Pittsburgh Medical Center, about who is most likely to be diagnosed, considerations when selecting the appropriate treatment for a patient, when to move on to a new treatment if there is not enough response, efficacy and side effects of biologic treatments and the role patient lifestyle and preference plays into treatment decisions.

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact